CVE-2022-23837

Public Exploit

Description

In api.rb in Sidekiq before 5.2.10 and 6.4.0, there is no limit on the number of days when requesting stats for the graph. This overloads the system, affecting the Web UI, and makes it unavailable to users.

Category

7.5
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.30%
Third-Party Advisory github.com Third-Party Advisory github.com Third-Party Advisory github.com Third-Party Advisory debian.org
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://github.com/mperham/sidekiq/commit/7785ac1399f1b28992adb56055f6acd88fd1d956 third party advisory patch
https://github.com/TUTUMSPACE/exploits/blob/main/sidekiq.md third party advisory exploit
https://github.com/rubysec/ruby-advisory-db/pull/495 third party advisory patch
https://lists.debian.org/debian-lts-announce/2022/03/msg00015.html third party advisory mailing list
https://lists.debian.org/debian-lts-announce/2023/03/msg00011.html mailing list

Frequently Asked Questions

What is the severity of CVE-2022-23837?
CVE-2022-23837 has been scored as a high severity vulnerability.
How to fix CVE-2022-23837?
To fix CVE-2022-23837, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-23837 being actively exploited in the wild?
It is possible that CVE-2022-23837 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.